Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

(2016) Melanie D Beaton   CANADIAN JOURNAL OF GASTROENTEROLOGY

Inflammatory Bowel Disease: A Canadian Burden of Illness Review

(2016) Angela Rocchi et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Comorbidity in inflammatory bowel disease

(2016) Antonio López San Román   WORLD JOURNAL OF GASTROENTEROLOGY

Physicians’ Practices for Diagnosing Liver Fibrosis in Chronic Liver Diseases: A Nationwide, Canadian Survey

(2016) Giada Sebastiani et al.   Canadian Journal of Gastroenterology and Hepatology

Incidence and Predictors of Hepatic Steatosis and Fibrosis by Serum Biomarkers in a Large Cohort of Human Immunodeficiency Virus Mono-Infected Patients

(2015) G. Sebastiani et al.   Open Forum Infectious Diseases

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

(2014) Juan Macías et al.   AIDS

Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease

(2014) E. Gizard et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis

(2014) Katsuyuki Fukuda et al.   BMC GASTROENTEROLOGY

Detection of liver injury in IBD using transient elastography

(2014) L.W.Y. Thin et al.   Journal of Crohns & Colitis

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance

(2014) Sabine Kahl et al.   PLoS One

Radiologic evaluation of nonalcoholic fatty liver disease

(2014) Seung Soo Lee   WORLD JOURNAL OF GASTROENTEROLOGY

Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)

(2013) Siddharth Verma et al.   LIVER INTERNATIONAL

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs

(2013) Hamid Hasson et al.   LIVER INTERNATIONAL

Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver

(2013) María Rojas-Feria   WORLD JOURNAL OF GASTROENTEROLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease

(2012) Achuthan Sourianarayanane et al.   Journal of Crohns & Colitis

How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?

(2012) G. Sebastiani et al.   JOURNAL OF VIRAL HEPATITIS

Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

(2012) A Barbero-Villares et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases

(2011) G. Sebastiani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients

(2011) Maud Lemoine et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis

(2011) Ruben Hernaez et al.   HEPATOLOGY

Changing shape of disease: Nonalcoholic fatty liver disease in Crohnʼs disease—A case series and review of the literature

(2011) Christopher E. McGowan et al.   INFLAMMATORY BOWEL DISEASES

Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis

(2010) N. Alcorn et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

(2010) Christopher D. Williams et al.   GASTROENTEROLOGY

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study

(2009) Ariel E. Feldstein et al.   HEPATOLOGY

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C

(2008) Satoru Yatsuji et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY